πŸ‡ΊπŸ‡Έ FDA
Patent

US 7320990

Crystalline form of a biphenyl compound

granted A61PA61P11/00

Quick answer

US patent 7320990 (Crystalline form of a biphenyl compound) held by Theravance, Inc. expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jan 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P11/00